Correlation Between Centessa Pharmaceuticals and HUTCHMED DRC
Can any of the company-specific risk be diversified away by investing in both Centessa Pharmaceuticals and HUTCHMED DRC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Centessa Pharmaceuticals and HUTCHMED DRC into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Centessa Pharmaceuticals PLC and HUTCHMED DRC, you can compare the effects of market volatilities on Centessa Pharmaceuticals and HUTCHMED DRC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Centessa Pharmaceuticals with a short position of HUTCHMED DRC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Centessa Pharmaceuticals and HUTCHMED DRC.
Diversification Opportunities for Centessa Pharmaceuticals and HUTCHMED DRC
0.17 | Correlation Coefficient |
Average diversification
The 3 months correlation between Centessa and HUTCHMED is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding Centessa Pharmaceuticals PLC and HUTCHMED DRC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on HUTCHMED DRC and Centessa Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Centessa Pharmaceuticals PLC are associated (or correlated) with HUTCHMED DRC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of HUTCHMED DRC has no effect on the direction of Centessa Pharmaceuticals i.e., Centessa Pharmaceuticals and HUTCHMED DRC go up and down completely randomly.
Pair Corralation between Centessa Pharmaceuticals and HUTCHMED DRC
Given the investment horizon of 90 days Centessa Pharmaceuticals PLC is expected to under-perform the HUTCHMED DRC. In addition to that, Centessa Pharmaceuticals is 1.17 times more volatile than HUTCHMED DRC. It trades about -0.04 of its total potential returns per unit of risk. HUTCHMED DRC is currently generating about 0.01 per unit of volatility. If you would invest 1,695 in HUTCHMED DRC on November 29, 2024 and sell it today you would lose (22.00) from holding HUTCHMED DRC or give up 1.3% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Centessa Pharmaceuticals PLC vs. HUTCHMED DRC
Performance |
Timeline |
Centessa Pharmaceuticals |
HUTCHMED DRC |
Centessa Pharmaceuticals and HUTCHMED DRC Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Centessa Pharmaceuticals and HUTCHMED DRC
The main advantage of trading using opposite Centessa Pharmaceuticals and HUTCHMED DRC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Centessa Pharmaceuticals position performs unexpectedly, HUTCHMED DRC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in HUTCHMED DRC will offset losses from the drop in HUTCHMED DRC's long position.Centessa Pharmaceuticals vs. Beam Therapeutics | Centessa Pharmaceuticals vs. Editas Medicine | Centessa Pharmaceuticals vs. Caribou Biosciences | Centessa Pharmaceuticals vs. Verve Therapeutics |
HUTCHMED DRC vs. ANI Pharmaceuticals | HUTCHMED DRC vs. Phibro Animal Health | HUTCHMED DRC vs. Prestige Brand Holdings | HUTCHMED DRC vs. Pacira BioSciences, |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |